Literature DB >> 30279819

Untreated cardiac sarcoidosis with active inflammation: Severe left ventricular dysfunction and ventricular wall thinning in three years.

Ryota Kakizaki1, Toshimi Koitabashi1, Yoshiyasu Minami1, Takeru Nabeta1, Toyoji Kaida1, Shunsuke Ishii1, Emi Maekawa1, Takayuki Inomata1, Junya Ako1.   

Abstract

A 74-year-old female was admitted for the treatment of complete atrioventricular block. Echocardiography showed thickening of interventricular septum and a slight thinning in the basal region with normal left ventricular (LV) function. She was clinically diagnosed with cardiac sarcoidosis accompanied by active inflammation from the findings of blood test, nuclear scanning, and magnetic resonance imaging. After pacemaker implantation, we recommended corticosteroid therapy, which she refused for the fear of side effects. Three years later, she was re-admitted to our hospital due to heart failure. Echocardiography showed severe LV systolic dysfunction and dilatation with wall thinning. Even though we started corticosteroid therapy and continued it for one year, LV function was not improved. In patients with cardiac sarcoidosis accompanied by active inflammation, LV dysfunction, and dilatation may rapidly progress. Early diagnosis and treatment with corticosteroid may be important to preserve cardiac function. <Learning objective: Left ventricular (LV) dysfunction in patients with cardiac sarcoidosis accompanied by active inflammation may rapidly progress in a short period. Corticosteroid therapy is demonstrated to improve the long-term clinical outcome, however, it may not be effective once LV function is worsened with wall thinning. Early diagnosis and treatment with corticosteroid may be important to preserve cardiac function in patients with cardiac sarcoidosis accompanied by active inflammation.>.

Entities:  

Keywords:  Cardiac sarcoidosis; Corticosteroid therapy; Echocardiography; Heart failure

Year:  2017        PMID: 30279819      PMCID: PMC6149286          DOI: 10.1016/j.jccase.2017.06.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  5 in total

1.  Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis.

Authors:  Toshiyuki Nagai; Nobutaka Nagano; Yasuo Sugano; Yasuhide Asaumi; Takeshi Aiba; Hideaki Kanzaki; Kengo Kusano; Teruo Noguchi; Satoshi Yasuda; Hisao Ogawa; Toshihisa Anzai
Journal:  Circ J       Date:  2015-04-16       Impact factor: 2.993

2.  Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis.

Authors:  Chiung-Zuan Chiu; Satoshi Nakatani; Guican Zhang; Teruo Tachibana; Fumio Ohmori; Masakazu Yamagishi; Masafumi Kitakaze; Hitonobu Tomoike; Kunio Miyatake
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

3.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

Authors:  A Uemura; S Morimoto; S Hiramitsu; Y Kato; T Ito; H Hishida
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

Review 4.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

Review 5.  Isolated cardiac sarcoidosis: clinical characteristics, diagnosis and treatment.

Authors:  Mitsuaki Isobe; Daisuke Tezuka
Journal:  Int J Cardiol       Date:  2014-12-23       Impact factor: 4.164

  5 in total
  1 in total

1.  Effective steroid therapy in an elderly patient with cardiac sarcoidosis and severe left ventricular dysfunction.

Authors:  Kyoko Odawara; Takahiro Inoue; Yoshitaka Hirooka
Journal:  J Cardiol Cases       Date:  2019-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.